Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CGTX
CGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CGTX News
Cognition Therapeutics Reports Better-Than-Expected FY GAAP EPS
5d ago
seekingalpha
Cognition Therapeutics Advances Zervimesine Clinical Development for DLB Psychosis
5d ago
Newsfilter
COGNITION THERAPEUTICS INC: FDA PSYCHIATRY DIVISION MEETING ANTICIPATED BY MID-2026
5d ago
moomoo
Cognition Therapeutics Reports FY Operating Loss of USD 47.799 Million
5d ago
moomoo
Cognition Advances Zervimesine Development for DLB Psychosis Treatment
Mar 02 2026
Newsfilter
Cognition Extends Expanded Access Program for DLB
Feb 05 2026
Newsfilter
Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise
Dec 17 2025
NASDAQ.COM
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO
Nov 26 2025
NASDAQ.COM
HC Wainwright & Co. Affirms Buy Rating for Cognition Therapeutics, Keeps $3 Price Target Intact
Nov 19 2025
Benzinga
Cognition Therapeutics Finishes Participant Enrollment for Phase 2 Trial of Zervimesine (CT1812) in Early Alzheimer's Disease
Nov 13 2025
Newsfilter
CGTX, RVPH, SHOT, SONN, AKTX Surge in After-Hours Trading Following Clinical Developments and Fed Rate Cut Expectations
Sep 18 2025
NASDAQ.COM
Biotech Stocks Surge After Hours Due to Trial Advancements, Funding Developments, and Anticipated Milestones
Sep 17 2025
NASDAQ.COM
Monday's Underperforming Sectors: General Contractors & Builders, Pharmaceuticals
Sep 15 2025
NASDAQ.COM
Cognition Therapeutics Achieves 75% Enrollment Goal for Zervimesine (CT1812) Study in Early Alzheimer's Disease
Sep 03 2025
Newsfilter
The 5 Best-Performing Stocks in the Nasdaq Composite for August 2025
Sep 03 2025
NASDAQ.COM
Snowflake Shares Surge 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 28 2025
Benzinga
Show More News
